Log In
person
Eisai Co Ltd
ESALF
summarize
4 total product lines
calendar_month
Revenue as of 03/31/2021
| Reporting Segmentarrow_drop_up | Product Line | Amount (JPY) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (JPY) | Percentage |
| License Revenue |
Pharmaceutical Patent Licensing
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
62.07B | 9.61% |
| Other Business |
Active Pharma Ingredients
These companies develop and manufacture Active Pharmaceutical Ingredients (APIs) that are used to create finished drugs.
|
33.93B | 5.25% |
| Pharmaceutical Business |
Branded Pharmaceuticals
These companies research, develop, and manufacture patented drugs.
|
524.79B | 81.24% |
| Pharmaceutical Business |
Over-the-Counter Pharmaceuticals
These companies research, develop, and manufacture over-the-counter (OTC) drugs, or those that do not require a doctor's prescription.
|
25.15B | 3.89% |
| keyboard_arrow_down |
License Revenue
Pharmaceutical Patent Licensing
|
62.07B | 9.61% |
| keyboard_arrow_right |
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
||
| keyboard_arrow_down |
Other Business
Active Pharma Ingredients
|
33.93B | 5.25% |
| keyboard_arrow_right |
These companies develop and manufacture Active Pharmaceutical Ingredients (APIs) that are used to create finished drugs.
|
||
| keyboard_arrow_down |
Pharmaceutical Business
Branded Pharmaceuticals
|
524.79B | 81.24% |
| keyboard_arrow_right |
These companies research, develop, and manufacture patented drugs.
|
||
| keyboard_arrow_down |
Pharmaceutical Business
Over-the-Counter Pharmaceuticals
|
25.15B | 3.89% |
| keyboard_arrow_right |
These companies research, develop, and manufacture over-the-counter (OTC) drugs, or those that do not require a doctor's prescription.
|
||